menu
    • menu

    List of key products of Piramal Pharma Solutions

    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Piramal Pharma Solutions (PPS) is a CDMO that provides end-to-end solutions for drug development and manufacturing across the drug life cycle to its clients in North America, Europe and Asia through a globally integrated network of facilities. It offers a range of services from drug discovery to commercial supply of APIs and finished dosage forms, along with specialized services like HPAPIs, antibody drug conjugations, sterile...
    Piramal Pharma Solutions (PPS) is a CDMO that provides end-to-end solutions for drug development and manufacturing across the drug life cycle to its clients in North America, Europe and Asia through a globally integrated network of facilities. It offers a range of services from drug discovery to commercial supply of APIs and finished dosage forms, along with specialized services like HPAPIs, antibody drug conjugations, sterile fill/finish, peptide products and services and potent solid oral drug products. PPS also provides services for biologics, including vaccines, gene therapies and monoclonal antibodies through its subsidiary Yapan Bio.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Piramal Pharma SolutionsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    18655 Krause St, Riverview, MI 48193
    Telephone
    Telephone
    +1 734 282 3370
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.piramalpharmasolutions.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/piramal-pharma-solutions/
    youtube
    YouTube
    Twitter
    Twitter
    https://twitter.com/PiramalPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    CPhI India 2024

    CPhI India 2024

    Not Confirmed

    envelop Contact Supplier

    CPhI India 2024

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “We have built considerable expertise in GLP-1 drug development through our oral peptide programs”

    “We have built considerable expertise in GLP-1 drug development through our oral peptide programs”

    This week, Speak Pharma interviews Dr. Andrew Lewis, Chief Scientific Officer at Quotient Sciences, a drug development and manufacturing accelerator that offers a range of integrated programs and tailored services to over 550 customers. Lewis discusses the latest developments in the delivery of oral peptides and how Quotient Sciences is helping customers overcome drug development challenges in this exciting space. 🔑HIGHLIGHTS// latest developments in the delivery of oral peptides Why have glucagon-like peptide-1 (GLP-1) therapies become essential for treating type 2 diabetes and obesity? What makes the oral delivery of peptides such as GLP-1 challenging? GLP-1 and gastric inhibitory polypeptide (GIP) are essential incretin hormones involved in regulating glucose metabolism. Both are produced in the gastrointestinal (GI) tract in response to food intake, specifically glucose and fats. GLP-1 enhances insulin secretion from the pancreas, but only in response to elevated blood glucose levels. GIP has overlapping effects that are slightly contradictory – it promotes the production of glucagon, which can counteract its glucose-lowering effects. In people with type 2 diabetes, the body’s response to incretin hormones is impaired. However, the GLP-1 pathway remains relatively intact, allowing it to still stimulate insulin production. There is a more significant impairment for GIP, making it not as effective. This makes GLP-1 a more attractive target for treatment, leading to the development of several GLP-1 receptor agonists for managing type 2 diabetes, obesity, and potentially other conditions. Incretin analogs, like GLP-1 agonists, have traditionally been challenging to deliver orally. As a result, these medications are most often given by injection. But we know that patients generally prefer taking a tablet or capsule treatment rather than an injection. Peptides such as GLP-1 analogs go through a challenging journey before being absorbed. This is because the gastrointestinal tract functions to digest these into either small amino acids or very short pieces of polypeptides. Even if they get to the epithelium, they tend to have poor permeability, usually resulting in less than 1 percent bioavailability (the proportion of a drug that enters the circulatory system when introduced into the body, thereby having an active effect). Various technologies have been developed to overcome bioavailability issues, with permeation enhancers being the most advanced and validated. For example, SNAC is the permeation enhancer used in Novo Nordisk’s oral pill Rybelsus to promote semaglutide absorption. Mycapssa (octreotide capsules), marketed by Chiesi, employs the Transient Permeation Enhancer (TPE) technology, which utilizes the medium-chain fatty acid (MCFA) sodium caprylate (C8) to augment the absorption of the somatostatin analog octreotide. At Quotient Sciences, over the last decade, we’ve worked on over 14 oral peptide programs and tested about a dozen different permeation enhancer combinations with them. Permeation enhancers tend to be required in large amounts in formulations, and many of them are usually waxy materials with poor flow, so the tablet formulation and manufacturing process require extra attention and careful design. From an analytics perspective, a lot of the standard quality control tests for tablets have been designed for small-molecule drugs and are yet to be optimized for use with peptides. 🔑HIGHLIGHTS// permeation enhancers as the most advanced and validated technology to overcome bioavailability issues/ worked on over 14 oral peptide programs/ tested about a dozen different permeation enhancer combinations How does Quotient Sciences handle the transition from pre-clinical to clinical development? We’ve pioneered an integrated approach through our Translational Pharmaceutics platform for drug development. This platform combines drug product manufacturing with clinical testing in healthy volunteers, allowing us to be incredibly adaptive in our phase I trial design. Through a tight integration of services, we can manufacture a drug, dose it in healthy volunteers, perform bioanalysis and pharmacokinetic analysis, and use data in real time to inform our next steps. In oral peptide programs, we’ve performed numerous studies where we’ve used this capability to optimize the formulation in response to the clinical data. Typical variables we’ve evaluated are the dose of the peptide and the levels of a permeation enhancer, allowing us to identify the relationship between them to maximize human bioavailability. Through our ability to see the full spectrum of data – from preclinical to clinical – for 11 different peptides and 10 different permeation enhancers, we have built up considerable expertise in the development of oral peptide drug products. This allows us to provide a more streamlined drug development process for our clients, as common challenges across programs can be readily overcome. 🔑HIGHLIGHTS// Translational Pharmaceutics platform for drug development/ combine drug product manufacturing with clinical testing in healthy volunteers/ use data in real time to inform next steps/ 11 different peptides and 10 different permeation enhancers What innovations do you see ahead for oral peptide delivery? I see a real convergence in advances in peptide drug discovery and engineering, together with advances in drug delivery that are really pushing the field forward. Technologies such as phage display mean that vast libraries of peptides can be screened for properties of interest. These are being applied to design peptides specifically for oral delivery. From a drug delivery perspective, approaches such as ingestible devices, ionic liquids and various technologies to exploit active uptake mechanisms are showing real promise. One challenge with oral peptide delivery technologies is that their effectiveness can be significantly impacted by food intake. However, I expect that in the coming years, new methods will be developed to mitigate these food-related effects. I also expect artificial intelligence (AI) to greatly benefit oral peptide delivery. In 2021, the US Food and Drug Administration reported it saw more than 100 drug and biologic application submissions containing elements of AI or machine learning (ML) used in the development process. So three to four years later, that number has likely only increased. All these developments promise to make oral peptide therapies more effective and convenient for patients in the years to come. 🔑HIGHLIGHTS// phage display to screen vast libraries of peptides for properties of interest/ ingestible devices, ionic liquids and various technologies to exploit active uptake mechanisms/ AI will greatly benefit oral peptide delivery To learn more about this topic, watch Quotient Sciences’ latest webinar featuring Dr. Andrew Lewis and Dr. Stuart Mair, Chief Medical Officer at Quotient Sciences. Watch it here.

    Impressions: 988

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/we-have-built-considerable-expertise-in-glp-1-drug-development-through-our-oral-peptide-programs

    #SpeakPharma With Quotient Sciences
    14 Oct 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    US, Europe turn to advanced manufacturing, stockpiling to strengthen drug supply chains

    US, Europe turn to advanced manufacturing, stockpiling to strengthen drug supply chains

    Over the last few decades, the United States and Europe have saved trillions of dollars by importing drugs from countries like China and India. Their journey wasn’t easy, with regulatory non-compliance and drug patent scams raising their ugly heads every now and then. The Covid-19 pandemic and the accompanying lockdowns were a wake-up call for these countries to take a long, hard look at their sourcing strategies.Over the last few years, both the US and Europe have embarked on policy changes and ambitious programs to strengthen their drug supply chains. PharmaCompass takes you through US and Europe’s journeys towards more robust pharmaceutical supply chains.Biden’s executive order, CARES Act, state-backed investments strengthen US supply chainDuring the early days of the pandemic, the US government (under former President Donald Trump)  had enacted the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) to address the economic fallout of the pandemic through a US$ 2.2 trillion stimulus. Through this act, the FDA had taken several drug shortage mitigation efforts. The new administration under President Joe Biden undertook more measures. Notable amongst them was Executive Order 14017 on America’s supply chains. It mandated a comprehensive 100-day review to identify vulnerabilities in key sectors, including pharmaceuticals and active pharmaceutical ingredients (APIs). The review noted that 87 percent of generic API facilities are located overseas, leaving the US healthcare system vulnerable to shortages of essential medicines.Through a Presidential Determination, Biden had also broadened US Department of Health and Human Services’ (HHS) authorities under the Defense Production Act (DPA) of 1950. HHS can now enable investment in domestic manufacturing of essential medicines and medical countermeasures under the DPA. The HHS has invested US$ 17 billion in domestic manufacturing for the medical supply chain, including US$ 500 million to support API manufacturing.Under this effort, Merck has been awarded a €121 million (US$ 132 million) government contract to set up a lateral flow membrane production facility at Sheboygan, Wisconsin. Similarly, California has launched an initiative (known as CalRx) and is working with CIVICA to make US$ 30 insulin available to all who need it.Europe encourages reshoring; EDQM develops monographs for unlicensed alternativesIn recent years, Europe has faced shortages of insulin, antibiotics, oncology drugs, corticosteroids and even paracetamol. To overcome these shortages, the European Medicines Agency (EMA) is encouraging drugmakers to enhance manufacturing capacity and diversify suppliers.There is change visible on the ground. Companies like Midas Pharma, EUROAPI, Seqens are setting up API plants in Europe. Seqens has taken steps to reshore paracetamol production in France and is constructing a new € 100 million (US$ 109 million) production unit in Roussillon. Sanofi is investing €1.3 billion (US$ 1.4 billion) in a new insulin production facility at its existing site in Frankfurt. Similarly, Sandoz has set up a new antibiotic production plant in Austria and a new biosimilar development center in Germany.That said, we know that manufacturing capacities take time to build and are often financially unviable in the developed world. Ergo, a particularly innovative initiative has come from the European Directorate for the Quality of Medicines & HealthCare (EDQM). Their project aims to develop monographs detailing the preparation and testing of unlicensed drugs that can fill the gap left when licensed medicinal products are unavailable. To facilitate this initiative, the European Pharmacopoeia Commission is recruiting experts to verify proposed production methods and analytical procedures.The other means of guarding against supply and demand fluctuations is stockpiling. The EMA has advised the European Commission (EC) and marketing authorization holders (MAH) to stockpile medicines. The regulator has also asked MAHs to establish a shortage prevention plan for critical medicines. Europe’s Health Emergency Response Authority (HERA) is taking a systematic approach to stockpile management.Despite these measures, costs and market structures pose serious challenges. Medicines for Europe, representing the generic and biosimilar medicines industry, has raised concerns about the current market structures. They argue that government purchasing practices, which prioritize obtaining the lowest prices for off-patent medicines, are jeopardizing the European manufacturing footprint and discouraging investments in supply chain resilience.FDA, EMA promote continuous manufacturing; US relies on digital stockpilesDuring the pandemic, there were acute shortages of oncology, cardiovascular, anesthesia, anti-infective, neurological and anti-allergic drugs in the US. A 2022 study undertaken by the Washington University points out that there is excess manufacturing capacity in the US that can be considered for reshoring critical and essential drugs. In fact, 49 percent of generic drug manufacturing capacity in the US is lying idle, and many others are working at less than 50 percent capacity. These capacities can be repurposed. Various advanced manufacturing technologies, such as  “continuous flow and on-demand manufacturing capabilities in idled manufacturing sites offer the ability to reduce production cost,” says this report.FDA has been promoting “advanced manufacturing” technologies, such as continuous manufacturing, which are now a part of America’s overall strategy to strengthen and secure the pharmaceutical supply chain. The EMA has also released guidelines on continuous manufacturing of drug substances and drug products. Advanced manufacturing is a collective term for new or innovative medical product manufacturing technologies. Unlike batch manufacturing, which involves sequential processing and testing of material across multiple discrete stages (and often discrete facilities), continuous manufacturing combines the full manufacturing stream into a single, fully integrated flow. While continuous manufacturing may not be suitable for every drug manufacturing process, but where applicable, it tends to eliminate built-in production gaps and shortens the time taken to manufacture a drug from months to days.In the US, the Strategic National Stockpile (SNS) plays a critical role in ensuring the availability of essential medical supplies during emergencies. It now also involves a digital stockpile that does not store physical goods and products. Instead, it stores electronic plans, instructions, and methods to make and test medical products. Digital stockpiles rely on one or more trusted suppliers that can make the product from the digital information, either through methods like 3D printing or self-contained distributed manufacturing lines.Our viewThe global pharmaceutical supply chain is a complex web spanning multiple countries and continents. While advanced manufacturing and stockpiling may work to an extent, a large chunk of generic drugs and APIs will continue to come from countries like China and India.In order to reduce reliance on China, the US has been proactively expanding its collaboration with India. But this time, there is increased emphasis on quality control. While FDA is increasing the number of inspections at Indian drug plants, the Indian government, on its part, has revised rules for drug manufacturing, with higher GMP standards.Taken together, a multi-pronged approach to addressing supply chain vulnerabilities should secure drug supplies to the US and Europe in the years to come.  
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 364

    https://www.pharmacompass.com/radio-compass-blog/us-europe-turn-to-advanced-manufacturing-stockpiling-to-strengthen-drug-supply-chains

    #Phispers by PHARMACOMPASS
    17 Oct 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Piramal Pharma Releases FY 2023-24 Sustainability Report
    Piramal Pharma Releases FY 2023-24 Sustainability Report

    04 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/piramal-pharma-releases-its-sustainability-report-for-fy-2023-24-under-the-theme-building-resilience-for-a-sustainable-tomorrow-302267649.html

    PR NEWSWIRE
    04 Oct 2024
    Share Share
    Piramal Pharma releases Sustainability Report FY 2023-24
    Piramal Pharma releases Sustainability Report FY 2023-24

    04 Oct 2024

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/piramal-pharma-releases-sustainability-report-fy-2023-24-16280

    INDPHARMAPOST
    04 Oct 2024
    Share Share
    Piramal to pump $80M into expansion of Kentucky injectables site
    Piramal to pump $80M into expansion of Kentucky injectables site

    02 Oct 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/piramal-pump-80m-expansion-kentucky-injectables-production-site

    FIERCE PHARMA
    02 Oct 2024
    Share Share
    Piramal Pharma Solutions Announces US$ 80 Million Expansion Plan
    Piramal Pharma Solutions Announces US$ 80 Million Expansion Plan

    01 Oct 2024

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/piramal-pharma-solutions-announces-us-80-million-expansion-plan-for-sterile-injectables-facility-in-kentucky-16266

    INDPHARMAPOST
    01 Oct 2024
    Share Share
    Piramal Pharma wants to be a $2 billion global firm by 2030
    Piramal Pharma wants to be a $2 billion global firm by 2030

    25 Sep 2024

    // CNBCTV

    https://www.cnbctv18.com/market/stocks/piramal-pharma-wants-to-be-a-2-billion-global-firm-by-2030-analysts-give-5-year-plan-a-thumbs-up-19482129.htm

    CNBCTV
    25 Sep 2024
    Share Share
    Piramal Pharma’s GHG commitment validated and approved by SBTi
    Piramal Pharma’s GHG commitment validated and approved by SBTi

    18 Sep 2024

    // EXPRESSPHARMA

    https://www.expresspharma.in/piramal-pharmas-ghg-commitment-validated-and-approved-by-sbti/

    EXPRESSPHARMA
    18 Sep 2024
    Share Share

    CEP/COS

    read-more
    read-more

    01

    Amiodarone hydrochloride

    CEP/COS

    34th IFSCC
    Not Confirmed
    arrow

    02

    Aprepitant, Form-I

    CEP/COS

    34th IFSCC
    Not Confirmed
    arrow

    03

    Baclofen

    CEP/COS

    34th IFSCC
    Not Confirmed
    arrow

    04

    Bisoprolol fumarate

    CEP/COS

    34th IFSCC
    Not Confirmed
    arrow

    05

    Brimonidine tartrate

    CEP/COS

    34th IFSCC
    Not Confirmed
    arrow

    06

    Buserelin

    CEP/COS

    34th IFSCC
    Not Confirmed
    arrow

    07

    Calcitonin (salmon), Synthetic

    CEP/COS

    34th IFSCC
    Not Confirmed
    arrow

    08

    Desmopressin

    CEP/COS

    34th IFSCC
    Not Confirmed
    arrow

    09

    Diltiazem hydrochloride

    CEP/COS

    34th IFSCC
    Not Confirmed
    arrow

    10

    Diltiazem hydrochloride, Process B

    CEP/COS

    34th IFSCC
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Services

    Upload your portfolio for free, ask us

    Packaging

    Click here to discover the service providers for Packaging

    Analytical

    Click here to discover the service providers for Analytical

    API Manufacturing

    Click here to discover the service providers for API Manufacturing

    Drug Product Manufacturing

    Click here to discover the service providers for Drug Product Manufacturing

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Piramal Pharma Solutions and get a quotation

    Piramal Pharma Solutions is a supplier offers 102 products (APIs, Excipients or Intermediates).

    Find a price of Diltiazem Hydrochloride bulk with DMF, CEP, JDMF, WC offered by Piramal Pharma Solutions

    Find a price of Ketoconazole bulk with DMF, CEP, JDMF, WC offered by Piramal Pharma Solutions

    Find a price of Amiodarone Hydrochloride bulk with DMF, CEP, WC offered by Piramal Pharma Solutions

    Find a price of Aprepitant bulk with DMF, CEP, WC offered by Piramal Pharma Solutions

    Find a price of Baclofen bulk with DMF, CEP, WC offered by Piramal Pharma Solutions

    Find a price of Bisoprolol Fumarate bulk with DMF, CEP, WC offered by Piramal Pharma Solutions

    Find a price of Entacapone bulk with DMF, CEP, WC offered by Piramal Pharma Solutions

    Find a price of Fosaprepitant bulk with DMF, JDMF, WC offered by Piramal Pharma Solutions

    Find a price of Perindopril Erbumine bulk with DMF, CEP, WC offered by Piramal Pharma Solutions

    Find a price of Pramipexole Dihydrochloride bulk with DMF, CEP, WC offered by Piramal Pharma Solutions

    Find a price of Trazodone Hydrochloride bulk with DMF, CEP, WC offered by Piramal Pharma Solutions

    Find a price of Verapamil Hydrochloride bulk with DMF, CEP, WC offered by Piramal Pharma Solutions

    Find a price of Desmopressin Acetate bulk with DMF, CEP offered by Piramal Pharma Solutions

    Find a price of Leuprolide Acetate bulk with DMF, CEP offered by Piramal Pharma Solutions

    Find a price of Oxytocin bulk with DMF, CEP offered by Piramal Pharma Solutions

    Find a price of Aciclovir bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Armodafinil bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Brimonidine Tartrate bulk with CEP, WC offered by Piramal Pharma Solutions

    Find a price of Cinacalcet Hydrochloride bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Clobazam bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Dabigatran Etexilate Mesylate bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Deferasirox bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Donepezil bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Flecainide bulk with CEP, WC offered by Piramal Pharma Solutions

    Find a price of Levobunolol bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Lurasidone Hydrochloride bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Mebeverine bulk with CEP, WC offered by Piramal Pharma Solutions

    Find a price of Misoprostol bulk with DMF, CEP offered by Piramal Pharma Solutions

    Find a price of Oxybutynin Hydrochloride bulk with CEP, WC offered by Piramal Pharma Solutions

    Find a price of Paliperidone Palmitate bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Rivaroxaban bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Sulindac bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Tetrabenazine bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Tramadol Hydrochloride bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Valacyclovir Hydrochloride bulk with DMF, WC offered by Piramal Pharma Solutions

    Find a price of Buserelin Acetate bulk with CEP offered by Piramal Pharma Solutions

    Find a price of Calcitonin bulk with CEP offered by Piramal Pharma Solutions

    Find a price of Cetrorelix Acetate bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Somatostatin bulk with CEP offered by Piramal Pharma Solutions

    Find a price of Terlipressin Acetate bulk with CEP offered by Piramal Pharma Solutions

    Find a price of Abacavir Sulfate bulk with WC offered by Piramal Pharma Solutions

    Find a price of Anagrelide Hydrochloride bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Arginine Vasopressin bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Azilsartan bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Bexagliflozin bulk with WC offered by Piramal Pharma Solutions

    Find a price of Cloprostenol Sodium bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Dapagliflozin Propanediol Monohydrate bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Dexlansoprazole bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Diltiazem Hydrochloride bulk with CEP offered by Piramal Pharma Solutions

    Find a price of Dronedarone Hydrochloride bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Droxidopa bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Empagliflozin bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Gemfibrozil bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Halothane bulk with WC offered by Piramal Pharma Solutions

    Find a price of Ibuprofen bulk with CEP offered by Piramal Pharma Solutions

    Find a price of Irbesartan bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Isoflurane bulk with WC offered by Piramal Pharma Solutions

    Find a price of Levoketoconazole bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Metaxalone bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Mirabegron bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Octreotide Acetate bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Octreotide Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Oxytocin bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Pregabalin bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Quetiapine Hemifumarate bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Tafenoquine Succinate bulk with WC offered by Piramal Pharma Solutions

    Find a price of Tolcapone bulk with WC offered by Piramal Pharma Solutions

    Find a price of Varenicline Tartrate bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Verapamil Hydrochloride bulk with CEP offered by Piramal Pharma Solutions

    Find a price of Vortioxetine Hydrobromide bulk with DMF offered by Piramal Pharma Solutions

    Find a price of Bexagliflozin bulk offered by Piramal Pharma Solutions

    Find a price of Carbetocin Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Gonadorelin Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Spironolactone bulk offered by Piramal Pharma Solutions

    Find a price of Tetracosactide bulk offered by Piramal Pharma Solutions

    Find a price of Abaloparatide Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Apixaban bulk offered by Piramal Pharma Solutions

    Find a price of Apremilast bulk offered by Piramal Pharma Solutions

    Find a price of Atosiban bulk offered by Piramal Pharma Solutions

    Find a price of Camylofin Dihydrochloride bulk offered by Piramal Pharma Solutions

    Find a price of Canagliflozin bulk offered by Piramal Pharma Solutions

    Find a price of Corticotropin bulk offered by Piramal Pharma Solutions

    Find a price of Degarelix Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Desvenlafaxine Succinate bulk offered by Piramal Pharma Solutions

    Find a price of Edoxaban Tosylate bulk offered by Piramal Pharma Solutions

    Find a price of Glatiramer Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Glucagon bulk offered by Piramal Pharma Solutions

    Find a price of Goserelin Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Lanreotide Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Lercanidipine bulk offered by Piramal Pharma Solutions

    Find a price of Linaclotide bulk offered by Piramal Pharma Solutions

    Find a price of Linagliptin bulk offered by Piramal Pharma Solutions

    Find a price of Liraglutide bulk offered by Piramal Pharma Solutions

    Find a price of Paliperidone bulk offered by Piramal Pharma Solutions

    Find a price of Plecanatide bulk offered by Piramal Pharma Solutions

    Find a price of Semaglutide bulk offered by Piramal Pharma Solutions

    Find a price of Sugammadex Sodium bulk offered by Piramal Pharma Solutions

    Find a price of Sulfiram bulk offered by Piramal Pharma Solutions

    Find a price of Teduglutide bulk offered by Piramal Pharma Solutions

    Find a price of Trientine Hydrochloride bulk offered by Piramal Pharma Solutions

    Find a price of Triptorelin Acetate bulk offered by Piramal Pharma Solutions

    Find a price of Valacyclovir bulk offered by Piramal Pharma Solutions

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search